Cosmos Health Inc. (COSM)
Nasdaq · Healthcare · Medical Distribution
$0.3457−9.03%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $34.8M
- Forward P/E
- 4.9
- 52-week range
- $0.162 – $1.32
- 52-week change
- −63.11%
- EPS (trailing)
- −$0.65
Fiscal year to Dec 2025
- Revenue
- $65.3M (+19.93%)
- Net income
- −$19.1M
- Operating margin
- −25.6%
- Diluted EPS
- −$0.63
- Free cash flow
- −$8.5M
From the company’s annual report on SEC EDGAR.
About Cosmos Health Inc.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand.
Headquarters: Thessaloniki, Greece · 163 employees · cosmoshealthinc.com